From Our Thought Leaders

Sherry Shao, Rotating CEO of GenScript, Celebrates MSCI's A Rating for Improved ESG Performance

"The A rating from MSCI is a significant recognition of our improvement in ESG performance," said Sherry Shao, Rotating CEO of GenScript. "We believe that integrating ESG principles into our operations improves our business resilience and positions u... Read more

14 October, 2024 | Monday | News
Americans Victor Ambros and Gary Ruvkun Win Nobel Prize in Medicine for Landmark Discovery of microRNA

The Nobel Prize in Physiology or Medicine has been awarded to American researchers Victor Ambros and Gary Ruvkun for their pioneering discovery of microRNA, a vital molecular mechanism that plays a key role in regulating gene activity. This breakth... Read more

07 October, 2024 | Monday | News
Sygnature Discovery Appoints Amira Modi as New Chief Operating Officer and Board Member

World-leading contract research organization (CRO) Sygnature Discovery is delighted to announce the appointment of Amira Modi as its new Chief Operating Officer (COO) and Board member.   Amira brings extensive experience from the life scienc... Read more

04 October, 2024 | Friday | News
Transforming Vision: Jacqueline Henderson on Johnson & Johnson's Groundbreaking IOL Innovations

As President of EMEA at Vision Johnson & Johnson, Jacqueline Henderson is at the forefront of innovation in ophthalmology, overseeing the development of advanced solutions for patients with eye health challenges. In this exclusive interview wit... Read more

01 October, 2024 | Tuesday | Interview

Bio Finance

Symbiosis Expands with £1.2M Barclays-Financed Acquisition of New 20,000 Sq/Ft Stirling Facility to Boost High-Tech Medicine Production

    Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1.2m from Barclays Corporate Bank PLC.   Symbiosis Pharmaceutical Services Ltd (Symbiosi... Read more

09 October, 2024 | Wednesday | News
Singular Genomics Receives $12.00 Per Share Acquisition Proposal from Concentra Biosciences

Singular Genomics Systems, a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentr... Read more

20 September, 2024 | Friday | News

Contract Services

Ardena Expands Global CDMO Footprint with Acquisition of Catalent’s Somerset Facility

  Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, announced it has signed a definitive agreement to acquire Catalent’s state... Read more

15 October, 2024 | Tuesday | News
NovaCina Expands Perth Facility with Advanced SA25 GMP Filling Line to Enhance Global CDMO Services

NovaCina, a global contract development and manufacturing organization (CDMO), has today announced the expansion of its facility in Perth, Australia with the introduction of a high-tech SA25 GMP filling line to assist customers with small-batch siz... Read more

08 October, 2024 | Tuesday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close